In conclusion, besides the well-known inflammatory markers CRP and IL-6, a panel of other cytokines such as IP10, sIL2Rα and IL-10 appear as very interesting tools to stratify COVID-19 patients, deserving possible new strategic intervention. This evidence concerns the gene IL10 and COVID-19.